| Home > Insurance Division > Life and Health > Life & Health Actuarial > HMO Performance Report |
2009 New Jersey HMO Performance Report |
| Getting Better/Living with Illness |
|
How well does the HMO care for members who are sick?
A comparison of each HMO’s performance to the New Jersey HMO average shows how effective the HMOs are in working with doctors to care for members who are sick or living with chronic illness.
|
| HMO |
Management of medicine for depression* |
Care after hospitalization for mental illness |
Appropriate medications for asthma (children)
|
Controlling high blood pressure |
| Aetna - HMO/POS |
68 |
80 |
96 |
71 |
| AmeriHealth - HMO/POS |
59 |
72 |
93 |
66 |
| CIGNA - HMO/POS |
66 |
69 |
94 |
64 |
| Health Net - HMO/POS |
67 |
82 |
96 |
71 |
| Horizon - HMO |
66 |
84 |
96 |
71 |
| Oxford - HMO/POS |
62 |
79 |
95 |
59 |
*Antidepressant Medication Management rate is based on Effective Acute Phase Treatment, as Optimal Practitioner Contacts for Medication Management retired this year. |
| |
Management of medicine for depression
People taking medicine for depression need to be monitored. Percent of members given medicine for depression who had follow-up visits: |
|
Care after hospitalization for mental illness
Therapy after a hospital stay for mental illness is important for recovery. Percent of members hospitalized for mental illness who received care afterwards: |
 |
|
 |
| |
|
|
Appropriate medications for asthma (children)
With appropriate therapies, long term control of persistent asthma can be achieved, resulting in a decrease in hospitalizations and emergency room visits for treatment. Percent of pediatric members aged 5–17 with persistent asthma who received an appropriate therapy in the past year: |
|
Controlling high blood pressure
High blood pressure (hypertension) is a major
risk factor for a number of diseases and must be
closely monitored and controlled. Percent of
members aged 18–85 with hypertension whose
blood pressure was under control at their most
recent medical visit: |
 |
|
 |
|
|
